FIELD: chemistry.
SUBSTANCE: invention relates to application of 2-R1-4-R2-6-polynitromethyl-1,3,5-triazines of general formula: , where n=0, X=NO2, Cl, Br, R1=R2=OR3, OAr (R3=CH3, C2H5, CH2(CH2)6CH3, CH2CH2Cl, Ar=metha-C6H4CH3), R1=OR3, OAr, R2=N(C2H5)2; n=1, X=Cl, R1=OR3, R2=NH(CH2)2NH2, N(CH2CH2)2NCH3 as compounds, which possess antibacterial activity.
EFFECT: identification of compounds based on 1,3,5-triazine derivatives, which possess high antibacterial activity.
3 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING 2,4-DIARYLOXY-6-TRINITROMETHYL-1,3,5-TRIAZINES | 2007 |
|
RU2361866C2 |
METHOD OF OBTAINING 2-AMINO-4,6-BIS(TRINITROMETHYL)-1,3,5-TRIAZINEV | 2006 |
|
RU2330026C2 |
METHOD OF PRODUCING 2,4-DIALKOXY-6-TRINITROMETHYL-1,3,5-TRIAZINES | 2006 |
|
RU2371435C2 |
N-SUBSTITUTED N'-(1-ALKYLTETRAZOLE-5-YL)-TRINITROACETIMIDAMIDES AND METHOD FOR PRODUCTION THEREOF | 2016 |
|
RU2677337C2 |
METHOD OF PRODUCING SODIUM SALTS OF 5-NRR-TETRAZOLO[1,5-a]-1,3,5-TRIAZIN-7-ONES | 2009 |
|
RU2433130C2 |
4-(2,4-DIMETHOXYPHENYL)-2-(2-HYDROXYPHENYL)-5,6-DIHYDRO-4N-BENZO[H]CHROMENE-3-CARBOXYLIC ACID, HAVING CYTOTOXIC ACTIVITY | 2019 |
|
RU2707972C1 |
AGENT FOR CANCER THERAPY | 2011 |
|
RU2471786C1 |
AGENT POSSESSING CYTOTOXIC ACTIVITY | 2019 |
|
RU2714932C1 |
1-HYDROXY- AND 1-METHOXY-2-(4-NITROPHENYL)IMIDAZOLE DERIVATIVES WITH ANTIVIRAL ACTIVITY AGAINST ORTHOPOXVIRUSES | 2022 |
|
RU2794763C1 |
N-(2-(2-(2-AZIDOETHOXY)ETHOXY)ETHYL)-4,6-DI(AZIRIDIN-1-YL)-1,3,5-TRIAZIN-2-AMINE, HAVING CYTOTOXIC ACTION | 2023 |
|
RU2825828C1 |
Authors
Dates
2015-02-20—Published
2013-07-02—Filed